2.45
Gridai Technologies Corp stock is traded at $2.45, with a volume of 53,292.
It is up +0.82% in the last 24 hours and up +2.51% over the past month.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
See More
Previous Close:
$2.43
Open:
$2.43
24h Volume:
53,292
Relative Volume:
0.47
Market Cap:
$8.24M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-1.0043
EPS:
-2.4396
Net Cash Flow:
$-5.70M
1W Performance:
+9.37%
1M Performance:
+2.51%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Gridai Technologies Corp Stock (GRDX) Company Profile
Name
Gridai Technologies Corp
Sector
Industry
Phone
561-589-7020
Address
433 PLAZA REAL, BOCA RATON
Compare GRDX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GRDX
Gridai Technologies Corp
|
2.45 | 8.24M | 0 | -6.24M | -5.70M | -2.4396 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Gridai Technologies Corp Stock (GRDX) Latest News
GridAI Regains Nasdaq Compliance After 10-K Filing Delay - TipRanks
GridAI Technologies Corp. (ENTO) back in Nasdaq compliance after delayed 10-K filing - Stock Titan
GridAI Technologies misses 10-K filing deadline; Nasdaq issues warning - MSN
The organic vs inorganic growth story at GridAI Technologies (GRDX) - Newser
GridAI Technologies Corp. (GRDX): AI Data Center Energy Optimization, Legacy Biopharma, and Corporate Transformation – 2025 Annual Report Highlights - Minichart
GridAI Technologies (Nasdaq: GRDX) pivots to AI energy while warning on going concern - Stock Titan
GridAI Technologies to Showcase AI-Powered Energy Platform at Market Movers Investor Summit - MEXC Exchange
GridAI Technologies Corp. to Present at the Market Movers Investor Summit - The Globe and Mail
GridAI heads to 48 Wall Street for a May 5 investor summit talk - Stock Titan
GridAI Technologies Receives Nasdaq Notice for Late 10-K Filing Following Grid AI Corp. Acquisition - Minichart
GridAI Technologies Faces Nasdaq Noncompliance Over Delayed 10-K - TipRanks
GridAI Technologies (NASDAQ: GRDX) flagged by Nasdaq for late 2025 10-K - Stock Titan
GridAI has until June 22 to submit Nasdaq plan over late annual report - Stock Titan
GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing - The Globe and Mail
Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. - MSN
GRDX (GridAI Technologies) posts wider than expected Q3 2024 per share loss, stock falls 1.09% in today’s session. - Newser
GridAI Technologies Faces Default on Revolving Loan Agreement - TipRanks
GridAI Technologies (GRDX) faces $1.01M default demand after loan maturity - Stock Titan
GRDX GridAI Technologies Corp. gains double digits despite posting a far wider than expected Q3 2024 per share loss.Risk Report - Cổng thông tin điện tử tỉnh Lào Cai
Is GridAI Technologies (GRDX) stock safe today | GridAI Technologies posts steep EPS miss, zero Q3 revenueCommunity Chart Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Grid AI Corp. Reports 2025 Financial Results: Acquisition of AMPx, Revenue Recognition, and Going Concern Risks Explained - Minichart
GRDX SEC FilingsGridAI Tech 10-K, 10-Q, 8-K Forms - Stock Titan
GridAI Technologies (NASDAQ: GRDX) adds Grid AI going-concern risk in major acquisition - Stock Titan
GRDX : GridAI Technologies Corp. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
GRDX Should I Buy - Intellectia AI
What is the future of GridAI Technologies (GRDX) Stock | Price at $2.14, Down 2.28%Most Watched Stocks - Newser
GRDX Stock Price, Quote & Chart | GRIDAI TECHNOLOGIES CORP (NASDAQ:GRDX) - ChartMill
GRDX: GridAI Technologies Corp.Full Company Report - Zacks Investment Research
GridAI Technologies (GRDX) Jumps 17.8% During the Day—Could This Signal a Bullish Turnaround? - Bitget
GridAI Technologies Delays Annual 10-K Filing - TipRanks
GridAI Technologies (ENTO) delays 2025 10-K amid acquisition accounting review - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
[RW] GridAI Technologies Corp. SEC Filing - Stock Titan
GridAI, Amp Z Team Up to Power 5GW of AI Data Centers - Environment+Energy Leader
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - DelmarvaNow.com
Gridai Technologies Corp (GRDX) Live Share Price, Invest From India - INDmoney
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
IBN announces latest episode of the TechMediaWire Podcast featuring Marshall Chapin, CEO of Grid AI Corp. - marketscreener.com
IBN Announces Latest Episode of The TechMediaWire Podcast featuring Marshall Chapin, CEO of Grid AI Corp. - The Manila Times
GridAI identifies Amp Z as previously announced AI data center developer - TipRanks
Gridai Technologies Corp Stock (GRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):